market strategi radar screen keep faith babi
industri theme sector
boxwork takeaway survey result
manag
manag meet new ceo run
novemb ghdx vote like result upward revis
note analyst day posit clinic updat includ
analyst certif import disclosur see
market strategi radar screen keep faith babi
industri theme sector
provid thought oct investor day reiter outperform rate compani recent announc
launch breakfast caus investor skeptic event shift execut stori investor
day specif expect econom impact relat next year breakfast launch formal guidanc
new long-term financi target anticip increment market cost breakfast weigh consensu
earn estim believ combin improv compstore acceler unit growth attract financi target
support outperform rate intrigu yield
under-perform broader biotech sector past two year vs nbi index
ytd vs nbi index signific portion driven investor fear regard robust
commerci treprostinil franchis opco/consensu expect q/q declin due gener remodulin entri
delay launch implant system remodulin isr key bulwark iv remodulin gener
pauciti identifi catalyst need re-rat stock think concern could allevi next
month mani busi fundament execut come fruition stay bullish
analyt collabor infrastructur softwar
boxwork takeaway survey result
last week attend work come away confid abil final succeed up-sel effort
view releas new relay workflow autom shield content/us secur product
believ broadli applic solut announc date sale leverag two
bundl digit workspac digit busi facilit effect sale motion believ still
earli evalu manag ambiti growth plan revenue growth margin feel
platform price ingredi need regain momentum independ survey show stronger yoy spend
intent clear interest shield maintain outperform
manag
recent attend investor meet cfo eric tanzberg treasur aaron foley compani long-term
growth stori continu tell well drawn leader billion deathcareindustri posit
capit favor demograph tailwind secur advanc market share via pre-ne sale consid babi
boomer gener progress come age increasingli consid pre-ne option
rel new mobil tablet-bas customer-fac technolog call beacon contribut elev funer pre-ne
sale growth anticip garner boost cemeteri pre-ne sale soon follow
anticip roll-out compar beacon cemeteri tool start
appreci rel resili revenu profil particularli time econom uncertainti solid free cash flow
gener fund growth initi tuck-in acquisit share repurchas grow dividend maintain
estim outperform rate
manag meet new ceo run
met manag includ new ceo sundaram nagarajan day focus naga view
busi model/technolog mutual fit/app naga board leadership
discuss appar fit culmin naga succeed michael hilton reflect similar operating/growth
cultur prior leadership role ceo focu anchor build compani foundat strength
technolog top pyramid serv applic custom intimacycomplementari attribut often
develop technolog iter custom perform object reinforc technolog distinct core
autom consum platform note eager engag humil clear recognit strong
organiz attribut legaci valu creation
novemb ghdx vote like result upward revis guidanc
genom health set novemb sharehold vote merger roughli month earlier
previous expect see materi gate factor complet transact believ deal may close
mid-novemb like upsid revenu estim assum genom revenu
contribut like reset manag guidanc around financi result confer call reflect
merger contribut earlier expect close support invest thesi call merger synergi
exceed manag target year three deliv acceler timelin posit cash flow
oper potenti begin
note analyst day posit clinic updat includ
analyst day report increment clinic data lead candid r/r follicular lymphoma
pivot ph trial on-going r/r small/chron lymphocyt leukemia sll/cll believ continu illustr
best-in-class potenti importantli evid substanti hypothesi intermitt dose
significantli mitig advers event risk associ inhibitor nonetheless gener meaning durabl
tumor respons believ grow investor recognit commerci prospect drive stock out-performance
septemb bway announc yaacov michlin resign ceo pursu busi opportun
believ drive forc michlin part way bway board desir increas manag us presenc
remind late august bway announc cfo hadar levi would reloc us israel take
role well bway board intend appoint us-bas ceo mr michlin successor bway co-found
chairman board dr david zacut serv interim ceo near-term disrupt risk manag
transit continu focu compani build opportun includ ocd smoking-cess ptsd data
latter two expect year-end
catabasi catb present find slide phase movedmd trial open-
label extens edasalonex intern annual congress world muscl societi present
reiter nf-b role dmd key factor diseas progress skelet cardiac muscl inhibit nf-b
target gene set peripher blood treatment edasalonex substanti slow dmd diseas progress
demonstr inflamm biomark serum c-reactiv protein muscl mri function endpoint nsaa
data strongli support on-going phase polarisdmd studi bullish view
highlight day good year tsmc digitim
gaa firm thrive robust vcsel pa rf demand digitim
open softwar star develop forum ee time
see number compani make proactiv strateg move capit rais expect
help compani work choppi macro environ side see move toward
comprehens offer growth area highlight time access
capit asset owner like nep effect announc rais equity-focus financ week give
platform flexibl growth util cheap debt addit continu see increment interest
sustain invest trend investor compani look differenti brand busi practic
pegi impact report dsji leadership recognit week exampl note polici support aid trend
dec cloud summit aw inventla vega nv
may biotech summit featur chemistri life process institutechicago
